CONTINUOUS INFUSION OF OCTREOTIDE IN ACROMEGALY
- 1 November 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 334 (8671) , 1083-1087
- https://doi.org/10.1016/s0140-6736(89)91092-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The Role of Somatostatin in the Regulation of Anterior Pituitary Hormone Secretion and the Use of Its Analogs in the Treatment of Human Pituitary TumorsEndocrine Reviews, 1988
- SMS 201–995 Induces a Continuous Decline in Circulating Growth Hormone and Somatomedin-C Levels During Therapy of Acromegalic Patients for Over Two YearsJournal of Clinical Endocrinology & Metabolism, 1987
- Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*Journal of Clinical Endocrinology & Metabolism, 1987
- The Response of Serum Growth Hormone Levels to the Long-Acting Somatostatin Analog SMS 201-995 in AcromegalyJournal of Clinical Endocrinology & Metabolism, 1987
- EFFECTIVE LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOGUE (SMS 201–995)Clinical Endocrinology, 1987
- Treatment of Resistant Acromegaly with a Long-Acting Somatostatin Analogue (SMS 201-995)Annals of Internal Medicine, 1986
- A Comparison among the Growth Hormone-Lowering Effects in Acromegaly of the Somatostatin Analog SMS 201-995, Bromocriptine, and the Combination of Both DrugsJournal of Clinical Endocrinology & Metabolism, 1986
- Therapeutic efficacy of a somatostatin analogue (SMS 201–995) in active acromegalyJournal of Neurosurgery, 1986
- Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administrationActa Endocrinologica, 1986
- Long term treatment of acromegaly with a long acting analogue of somatostatin.BMJ, 1985